Abstract
For more than 2 years, health care systems have been floundering in a massive crisis of coronavirus disease 2019 (COVID-19) pandemic. While acute respiratory distress syndrome is the main complication in patients with COVID-19, as the pandemic continues, more data about the nonrespiratory effects of the coronavirus is obtained, including developing Coagulopathy-related manifestations, in the form of venous and arterial thromboembolism. Although arterial thrombosis a rare complication of this disease, it proves to be an effective factor in the mortality and morbidity of COVID-19 patients. The pathophysiology of thrombosis reveals a complex relation between hemostasis and immune system that can be disrupted by COVID-19. Thrombectomy, anticoagulant therapy, and thrombolysis are the main treatments in these patients. In addition, appropriate thromboprophylaxis treatment should be considered in COVID-19 patients. In this article, we have successfully reviewed the arterial thrombotic events in patients reported around the world, including the diagnostic and management method of choice.
【초록키워드】 COVID-19, Treatment, coronavirus disease, coronavirus, pandemic, Mortality, thrombosis, diagnostic, immune system, Hemostasis, pathophysiology, management, morbidity, Patient, Thromboembolism, Manifestations, disease, Health care system, patients, COVID-19 patients, acute respiratory distress, Thromboprophylaxis, Thrombectomy, anticoagulant therapy, complex, syndrome, while, Effect, effective, venous, thrombotic event, reported, addition, reveal, patients with COVID-19, 【제목키워드】 COVID-19, review, Artery, peripheral, MINI,